The three year project, which is co-funded by the Biotechnology and Biological Sciences Research Council (BBSRC) aims to design new polymers, using the Company’s novel and proprietary encapsulation technologies, for stem cell culture and differentiation to facilitate stem cell research applications.
Stem cells can be transformed into any cell in the body and can potentially be used to replace damaged or diseased cells, tissues and organs. Stem cell research is therefore considered vitally important in the research into potential cures of a range of debilitating diseases.
This affiliation brings together Chromatide's extensive experience in polymer design and synthesis, with the considerable expertise of Professor Jerry Turnbull and Dr Patricia Murray in stem cell biology and cell signalling research.
Commenting on the announcement, Dr Don Wellings, Chromatide’s CSO, said, “We are delighted to be working with the University of Liverpool on this project”.
He added, “It illustrates how we are applying our proprietary technologies in a range of applications which are at the forefront of key life science research applications. The relationship is enabling us to combine our expertise in developing novel polymer technologies with the skills and knowledge that Professor Turnbull and Dr Murray have in this growing and exciting research area”.
Professor Turnbull, from University of Liverpool added, “The Chromatide team has many years experience in polymer technologies. Our collaboration to develop novel polymers for use in stem cell cultures will enable us to quickly develop improved cell culture techniques”.